Financials

News Discussions Technicals Forecast Seasonals

145020 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. Its products include botulinum toxin, hyaluronic acid fillers, facial masks, concealers, and moisturizers. The company was founded on November 22, 2001 and is headquartered in Chuncheon-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

145020 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company